Department of Defense | Breast Cancer Research Program

The BCRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY22 funding opportunities. This pre-announcement should not be construed as an obligation by the government. The FY22 BCRP funding opportunity announcements for the following award mechanisms will be posted on the Grants.gov website. Pre-application and application deadlines will be available when the announcements are released.

Applications submitted to the FY22 BCRP must address one or more of the following overarching challenges:

  • Prevent breast cancer (primary prevention)
  • Identify determinants of breast cancer initiation, risk, or susceptibility
  • Distinguish deadly from non-deadly breast cancers
  • Conquer the problems of overdiagnosis and overtreatment
  • Identify what drives breast cancer growth; determine how to stop it
  • Identify why some breast cancers become metastatic
  • Determine why/how breast cancer cells lie dormant for years and then re-emerge; determine how to prevent lethal recurrence
  • Revolutionize treatment regimens by replacing them with ones that are more effective, less toxic, and impact survival
  • Eliminate the mortality associated with metastatic breast cancer
Eligibility

Investigators at all academic levels are encouraged to explore these funding opportunities.

See Full Eligibility & Application Details


Agency Name: 
Department of Defnse Congressionally Directed Medical Research Programs (CDMRP)
Contact Name: 
Keiko McFarland (oris.health@uleth.ca)
Grant Amount: 
Vaires
Grant Location: 
External
Grant Type: 
Research
Salary
Events
Travel
Equipment
Grant Area: 
Health
Grant Eligibility: 
Faculty